Ovarian cancer
Results
Phase 3
This trial looked at a drug called niraparib for ovarian cancer, fallopian tube cancer or primary peritoneal cancer. It was for women whose cancer had come back after treatment with chemotherapy that included a platinum drug.
Recruitment start: 1 August 2013
Recruitment end: 7 April 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jonathan Ledermann
NIHR Clinical Research Network: Cancer
TESARO
Last reviewed: 11 December 2017
CRUK internal database number: 11348
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
